Concepedia

Chul Kim

CK

Statistics

Publications

65

Citations

2.8K

H-Index

30

Active since

1960

Affiliations

Georgetown University(Current)

Georgetown University Medical Center

Center for Cancer Research

MedStar Georgetown University Hospital

National Cancer Institute

Chul Kim is an author at Georgetown University specializing in oncology, medicine, and life sciences.

Publications per year

1960–2025

65

Publications

65

Pembrolizumab in patients with thymic carcinoma: a single-arm, single-centre, phase 2 study

Giuseppe Giaccone, Chul Kim, Jillian Thompson et al. · The Lancet Oncology · 2018 · 400 citations · Full text

Medicine, Oncology, Pharmacology +10

Clonal Evolution and Heterogeneity of Osimertinib Acquired Resistance Mechanisms in EGFR Mutant Lung Cancer

Nitin Roper, Anna‐Leigh Brown, Jun S. Wei et al. · Cell Reports Medicine · 2020 · 181 citations · Full text

Medicine, Genetics, Oncology +17

Strength of Validation for Surrogate End Points Used in the US Food and Drug Administration's Approval of Oncology Drugs

Chul Kim, Vinay Prasad · Mayo Clinic Proceedings · 2016 · 126 citations

Pharmacy, Oncology, Pharmacology +17

Safety and efficacy of immune checkpoint inhibitors (ICIs) in cancer patients with HIV, hepatitis B, or hepatitis C viral infection

Neil J. Shah, Ghassan Al‐Shbool, Matthew Blackburn et al. · Journal for ImmunoTherapy of Cancer · 2019 · 120 citations · Full text

Life Sciences, Immunology, Oncology +17

Phase I study of the <sup>177</sup>Lu-DOTA<sup>0</sup>-Tyr<sup>3</sup>-Octreotate (lutathera) in combination with nivolumab in patients with neuroendocrine tumors of the lung

Chul Kim, Stephen V. Liu, Deepa S. Subramaniam et al. · Journal for ImmunoTherapy of Cancer · 2020 · 85 citations · Full text

Medicine, Oncology, Pharmacology +17

1–5 of 65